查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1592900

感染监测解决方案市场：按产品、部署和最终用户 - 2025-2030 年全球预测

Infection Surveillance Solution Market by Product (Services, Software), Deployment (On-Cloud, On-Premise), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年感染监测解决方案市值为7.6847亿美元，预计2024年将达到8.6799亿美元，复合年增长率为13.36%，到2030年将达到18.4973亿美元。

感染监测解决方案 (ISS) 包括旨在监测、预防和控制感染疾病的综合系统和方法，特别是在医疗保健环境中。这些解决方案包括软体平台、分析工具和即时资料监控系统。这项需求源自于控制医疗保健相关感染（HAIs）、优化抗生素使用和提高病人安全的迫切需要，这在抗药性病原体和医院感染增加的推动下极为重要。应用领域包括医院、门诊病人设施和辅助生活设施，使其成为感染预防团队、流行病学家和医疗保健管理者的重要工具。 ISS 市场的开拓主要是由人们对 HAI 的认识不断提高、政府对感染控制措施的要求以及医疗基础设施的持续发展（尤其是在新兴市场）所推动的。此外，资料分析中的机器学习和人工智慧等技术进步透过实现更具预测性和个人化的感染控制措施提供了潜在的机会。然而，初始成本高、与现有医院资讯系统整合的复杂性以及资料隐私问题等限制构成了重大挑战。此外，新兴市场缺乏意识和基础设施不足正在阻碍市场渗透和成长。开发可与不同医疗 IT 系统无缝整合的可互通平台、利用人工智慧预测分析进行早期感染预警以及利用穿戴式技术进行即时病患监测，存在巨大的创新机会。该市场主要是技术主导的，重点关注医疗保健领域的数位转型。因此，寻求发展的公司应该投资于增强系统互通性和使用者介面设计的研发，并确保遵守资料保护条例。鑑于世界日益增长的健康问题，这些策略倡议可以使公司成为感染预防技术​​的领导者，推动市场发展并改善公共卫生。

主要市场统计
基准年[2023] 7.6847亿美元
预测年份 [2024] 86799万美元
预测年份 [2030] 1,849.73 百万美元
复合年增长率（%） 13.36%

市场动态：针对快速发展的感染监测解决方案市场揭示的关键市场洞察

供需的动态交互作用正在改变感染监测解决方案市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 老年人口增加和慢性病增加
    • 院内感染 (HAI) 增加
    • 更多采用抗菌药物管理计划
  • 市场限制因素
    • 部署感染监测解决方案相关的高成本
  • 市场机会
    • 透过与电子健康记录整合开发全自动感染监测解决方案系统
    • 云端基础的感染监测解决方案迅速崛起
  • 市场挑战
    • 缺乏熟练的医疗保健 IT 专业人员

波特五力：引领感染监测解决方案市场的策略工具

波特的五力框架是了解感染监控解决方案市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解感染监测解决方案市场的外部影响

外部宏观环境因素在塑造感染监控解决方案市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解感染监测解决方案市场的竞争格局

对感染监控解决方案市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵感染监测解决方案市场供应商绩效评估

FPNV 定位矩阵是评估感染监控解决方案市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划感染监测解决方案市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对感染监控解决方案市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 人口老化加剧，慢性病发生率上升
      • 院内感染 (HAI) 盛行率增加
      • 更多地引入抗菌药物管理计划
    • 抑制因素
      • 实施感染监测解决方案相关的高成本
    • 机会
      • 开发整合电子健康记录的全自动感染监测解决方案系统
      • 云端基础的感染监测解决方案迅速兴起
    • 任务
      • 缺乏熟练的医疗保健 IT 专业人员
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章感染监测解决方案市场：依产品

  • 服务
    • 实施服务
    • 产品支援和维护服务
    • 培训和咨询服务
  • 软体
    • 抗菌监测和控制
    • 感染监测
      • 实验室监测
      • 手术监测和病患监测
    • 疫情管理
      • 检疫管理
      • 警告潜在的感染传播
    • 员工健康和合规性

第七章感染监测解决方案市场：依部署

  • 在云端
  • 本地

第 8 章感染监测解决方案市场：按最终用户分类

  • 医院
  • 研究所
  • 长期照护设施

第九章美洲感染监测解决方案市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太感染监测解决方案市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的感染监测解决方案市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Orbis Protect 收购了 Secure Site UK，以进一步加强其安全解决方案和服务产品。
    • 西哈特福德-布鲁姆菲尔德卫生区的医疗保健相关感染控制联盟团队被评为 NACCHO 感染预防和控制冠军。
    • 一家美国公司被指定为该 2000 万英镑（2406 万美元）框架的唯一供应商。
    • Foresight Group 已从其 Midlands Engine Investment Fund 向 ReadyGo Diagnostics Limited 追加投资 100 万英镑（120 万美元）。
    • RACGP 发布了新的感染预防和控制指南。
    • 麻省理工学院的化学家开发了用于生物感测的无线电子横向流动化验测试。
    • 感染防治线上学习已启动。
    • Premier 将 PINC AI 临床监测技术部署到长期照护机构。
    • Bitscope 临床监测软体将在 VA 洛杉矶和 VA 拉斯维加斯实施。
  • 战略分析和建议

公司名单

  • 3M Company
  • Altarum
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • BioVigil Healthcare Systems, Inc.
  • Cardinal Health Inc.
  • CenTrak, Inc.
  • Clinsys, Inc.
  • Conduent, Inc.
  • Datlowe, sro
  • DNV AS
  • Ecolab Inc.
  • Gunnebo Entrance Control Ltd.
  • Health Matrix.
  • Ibhar Technologies Pvt Ltd
  • Inovalon
  • International Business Machines Corporation
  • Medexter Healthcare GmbH
  • Oracle Corporation
  • PointClickCare
  • Premier Inc.
  • RLDatix
  • Securitas Healthcare, LLC.
  • Strategic Solutions Group
  • Thermo Fisher Scientific Inc.
  • Vecna Technologies, Inc.
  • VigiLanz Corporation
  • Vitalacy Inc.
  • Vizzia Technologies
  • Wolters Kluwer NV
Product Code: MRR-43127F727969

The Infection Surveillance Solution Market was valued at USD 768.47 million in 2023, expected to reach USD 867.99 million in 2024, and is projected to grow at a CAGR of 13.36%, to USD 1,849.73 million by 2030.

Infection Surveillance Solutions (ISS) involve comprehensive systems and methodologies designed to monitor, prevent, and manage infections, especially within healthcare settings. These solutions encompass software platforms, analytical tools, and real-time data monitoring systems. Their necessity stems from the urgent need to curtail healthcare-associated infections (HAIs), optimize antibiotic use, and enhance patient safety, which are critical due to increasing drug-resistant pathogens and nosocomial infections. Application areas include hospitals, outpatient facilities, and assisted living environments, serving as instrumental tools for infection prevention teams, epidemiologists, and healthcare administrators. The market for ISS is primarily driven by heightened awareness around HAIs, government mandates for infection control, and the continuous evolution of healthcare infrastructure, particularly in developed regions. Additionally, technological advancements such as machine learning and AI in data analytics offer potential opportunities by enabling more predictive and personalized infection control measures. However, limitations like high initial costs, integration complexities with existing hospital information systems, and data privacy concerns pose significant challenges. Further, a lack of awareness and inadequate infrastructure in developing regions hinder market penetration and growth. The best opportunity for innovation lies in developing interoperable platforms that can seamlessly integrate with diverse health IT systems, adopting AI-enabled predictive analytics for early infection warning, and harnessing wearable technology for real-time patient monitoring. The market is largely technology-driven, with a dynamic focus on digital transformation in healthcare. Thus, businesses aiming for growth should invest in R&D that enhances system interoperability and user interface design, ensuring compliance with data protection regulations. Given the increasing global health concerns, such strategic moves could position a company as a leader in infection prevention technology, driving market evolution and public health improvements.

KEY MARKET STATISTICS
Base Year [2023] USD 768.47 million
Estimated Year [2024] USD 867.99 million
Forecast Year [2030] USD 1,849.73 million
CAGR (%) 13.36%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infection Surveillance Solution Market

The Infection Surveillance Solution Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing geriatric population coupled with increasing incidences of chronic diseases
    • Increasing prevalence of hospital-acquired infections (HAIs)
    • Rising adoption of antimicrobial stewardship programs
  • Market Restraints
    • High cost associated with the deployment of infection surveillance solutions
  • Market Opportunities
    • Development of fully automated infection surveillance solution systems with the integration of electronic medical records
    • Rapid emergence of cloud based infection surveillance solutions
  • Market Challenges
    • Limited availability of skilled healthcare IT professional

Porter's Five Forces: A Strategic Tool for Navigating the Infection Surveillance Solution Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infection Surveillance Solution Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infection Surveillance Solution Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infection Surveillance Solution Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infection Surveillance Solution Market

A detailed market share analysis in the Infection Surveillance Solution Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infection Surveillance Solution Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infection Surveillance Solution Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infection Surveillance Solution Market

A strategic analysis of the Infection Surveillance Solution Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infection Surveillance Solution Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Altarum, Baxter International, Inc., Becton, Dickinson and Company, bioMerieux SA, BioVigil Healthcare Systems, Inc., Cardinal Health Inc., CenTrak, Inc., Clinsys, Inc., Conduent, Inc., Datlowe, s.r.o., DNV AS, Ecolab Inc., Gunnebo Entrance Control Ltd., Health Matrix., Ibhar Technologies Pvt Ltd, Inovalon, International Business Machines Corporation, Medexter Healthcare GmbH, Oracle Corporation, PointClickCare, Premier Inc., RLDatix, Securitas Healthcare, LLC., Strategic Solutions Group, Thermo Fisher Scientific Inc., Vecna Technologies, Inc., VigiLanz Corporation, Vitalacy Inc., Vizzia Technologies, and Wolters Kluwer N.V..

Market Segmentation & Coverage

This research report categorizes the Infection Surveillance Solution Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Services and Software. The Services is further studied across Implementation Services, Product Support & Maintainnace Services, and Training & Consulting Services. The Software is further studied across Antimicrobial Monitoring & Control, Infection Surveillance, Outbreak Management, and Staff Health & Compliance. The Infection Surveillance is further studied across Laboratory surveillance and Surgical surveillance & patient monitoring. The Outbreak Management is further studied across Isolation Management and Potential Outbreak Alert.
  • Based on Deployment, market is studied across On-Cloud and On-Premise.
  • Based on End-User, market is studied across Hospital, Laboratories, and Long-Term Care Facility.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing geriatric population coupled with increasing incidences of chronic diseases
      • 5.1.1.2. Increasing prevalence of hospital-acquired infections (HAIs)
      • 5.1.1.3. Rising adoption of antimicrobial stewardship programs
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the deployment of infection surveillance solutions
    • 5.1.3. Opportunities
      • 5.1.3.1. Development of fully automated infection surveillance solution systems with the integration of electronic medical records
      • 5.1.3.2. Rapid emergence of cloud based infection surveillance solutions
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of skilled healthcare IT professional
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infection Surveillance Solution Market, by Product

  • 6.1. Introduction
  • 6.2. Services
    • 6.2.1. Implementation Services
    • 6.2.2. Product Support & Maintainnace Services
    • 6.2.3. Training & Consulting Services
  • 6.3. Software
    • 6.3.1. Antimicrobial Monitoring & Control
    • 6.3.2. Infection Surveillance
      • 6.3.2.1. Laboratory surveillance
      • 6.3.2.2. Surgical surveillance & patient monitoring
    • 6.3.3. Outbreak Management
      • 6.3.3.1. Isolation Management
      • 6.3.3.2. Potential Outbreak Alert
    • 6.3.4. Staff Health & Compliance

7. Infection Surveillance Solution Market, by Deployment

  • 7.1. Introduction
  • 7.2. On-Cloud
  • 7.3. On-Premise

8. Infection Surveillance Solution Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospital
  • 8.3. Laboratories
  • 8.4. Long-Term Care Facility

9. Americas Infection Surveillance Solution Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Infection Surveillance Solution Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Infection Surveillance Solution Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Orbis Protect Acquires Secure Site UK to Further Enhance Their Security Solutions & Service Offering.
    • 12.3.2. West Hartford-Bloomfield Health District Coalition Against Healthcare-Acquired Infections Team Recognized as NACCHO Infection Prevention and Control Champion.
    • 12.3.3. American Firm Named as Sole Supplier For £20m (USD 24.06 Million) Framework.
    • 12.3.4. Foresight Group Invests Additional £1 Million (USD 1.20 Million) from the Midlands Engine Investment Fund into ReadyGo Diagnostics Limited.
    • 12.3.5. RACGP Launches New Infection Prevention and Control Guidelines.
    • 12.3.6. MIT Chemists Develop a Wireless Electronic Lateral Flow Assay Test for Biosensing.
    • 12.3.7. Infection Prevention and Control Online Learning Launched.
    • 12.3.8. Premier Brings PINC AI Clinical Surveillance Technology to Long-Term Care Facilities.
    • 12.3.9. Bitscopic's Clinical Surveillance Software to be Implemented at VA Los Angeles and VA Las Vegas.
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Altarum
  • 3. Baxter International, Inc.
  • 4. Becton, Dickinson and Company
  • 5. bioMerieux SA
  • 6. BioVigil Healthcare Systems, Inc.
  • 7. Cardinal Health Inc.
  • 8. CenTrak, Inc.
  • 9. Clinsys, Inc.
  • 10. Conduent, Inc.
  • 11. Datlowe, s.r.o.
  • 12. DNV AS
  • 13. Ecolab Inc.
  • 14. Gunnebo Entrance Control Ltd.
  • 15. Health Matrix.
  • 16. Ibhar Technologies Pvt Ltd
  • 17. Inovalon
  • 18. International Business Machines Corporation
  • 19. Medexter Healthcare GmbH
  • 20. Oracle Corporation
  • 21. PointClickCare
  • 22. Premier Inc.
  • 23. RLDatix
  • 24. Securitas Healthcare, LLC.
  • 25. Strategic Solutions Group
  • 26. Thermo Fisher Scientific Inc.
  • 27. Vecna Technologies, Inc.
  • 28. VigiLanz Corporation
  • 29. Vitalacy Inc.
  • 30. Vizzia Technologies
  • 31. Wolters Kluwer N.V.

LIST OF FIGURES

  • FIGURE 1. INFECTION SURVEILLANCE SOLUTION MARKET RESEARCH PROCESS
  • FIGURE 2. INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INFECTION SURVEILLANCE SOLUTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INFECTION SURVEILLANCE SOLUTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFECTION SURVEILLANCE SOLUTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFECTION SURVEILLANCE SOLUTION MARKET DYNAMICS
  • TABLE 7. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY IMPLEMENTATION SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT SUPPORT & MAINTAINNACE SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY TRAINING & CONSULTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ANTIMICROBIAL MONITORING & CONTROL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LABORATORY SURVEILLANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SURGICAL SURVEILLANCE & PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ISOLATION MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY POTENTIAL OUTBREAK ALERT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STAFF HEALTH & COMPLIANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-CLOUD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY ON-PREMISE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY LONG-TERM CARE FACILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 86. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 93. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 100. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 107. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 112. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 114. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 121. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 126. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 128. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 135. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 142. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 149. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 156. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 163. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 176. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 178. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 185. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 192. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 197. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 198. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 199. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 205. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 206. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 213. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 218. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 220. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 227. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 232. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 233. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 234. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 240. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 241. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 246. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 247. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 248. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 253. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 254. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 255. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 260. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 261. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 262. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 269. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 281. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 282. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 283. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 288. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 289. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 290. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 296. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 297. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 302. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 303. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 304. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY INFECTION SURVEILLANCE, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY OUTBREAK MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY DEPLOYMENT, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 309. UNITED ARAB EMIRATES INFECTION SURVEILLANCE SOLUTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)

TA